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Could leprosy reaction episodes be exacerbated by oral infections?
Episódios reacionais da hanseníase podem ser exacerbados por infecções orais?
Ana Carolina Fragoso Motta1, Renata Bazan Furini2, João Carlos Lopes Simão2, Mariana Bellini Vieira2, 
Maria Aparecida Nunes Ferreira2, Marilena Chinali Komesu1 and Norma Tiraboschi Foss2
ABSTRACT
Introduction: This study evaluated whether leprosy reactions could be 
associated with oral infection. Methods: Leprosy patients (n = 38) with 
(group I) and without (group II) oral infections were selected. Reactions 
were identified from the clinical and histopathological features associated 
with serum C-reactive protein (CRP) and10kDa interferon-gamma-induced 
protein (IP-10) levels, determined before and after elimination of the foci of 
infection. Results: group I presented more reactions than group II did, and 
improvement of the reactions after dental treatment. Serum CRP and IP-10 
did not differ before and after the dental treatment, but differed between 
the groups. Conclusions: Oral infection could be an exacerbating factor 
in leprosy reactions. 
Keywords: Leprosy reaction episodes. Oral infection. Inflammatory 
markers.
RESUMO
Introdução: Este estudo avaliou se as reações hansênicas podem estar 
associadas a infecções orais. Métodos: Pacientes com hanseníase (n=38) 
com (grupo I) e sem (grupo II) infecções orais foram selecionados. As 
reações foram identificadas pelas características clínicas, histopatológicas, 
associadas a proteína-C-reativa (PCR) e proteína indutora de interferon-
gamma de 10kDa (IP-10) séricos determinados antes e após a eliminação 
dos focos de infecção. Resultados: grupo I apresentou mais reações que o 
grupo II, e melhora das reações após o tratamento odontológico. PCR e IP-
10 séricos não diferiram antes e após o tratamento odontológico, entretanto 
diferiram entre os grupos. Conclusões: As infecções orais podem ser 
exacerbadores das reações hansênicas. 
Palavras-chaves: Episódios reacionais da hanseníase. Infecções orais. 
Marcadores inflamatórios.
Reactional episodes are a serious problem during the course of 
leprosy since they may be responsible for much of the permanent 
nerve damage, thus leading to disability and deformities1. These 
episodes represent an exacerbation of the inflammatory process 
that can occur before, during or after leprosy treatment [multidrug 
therapy/World Health Organization (MDT - WHO)]2,3. There are 
two well recognized main types of reaction: reversal reaction (RR) 
and erythema nodosum leprosum (ENL). Reversal reactions may be 
due to an increase in the cell-mediated response to Mycobacterium 
leprae characterized by a Th1 response. Erythema nodosum leprosum 
is a systemic inflammatory process characterized by intralesional 
neutrophilic infiltration and by a Th2 response3,4. Since both types 
of reaction are accompanied by increased release of the inflammatory 
markers5-7, it is reasonable to consider the possibility that these 
episodes may be associated with an infectious process, such as dental 
abscess or periodontal diseases. These may induce overstimulation 
of the host immune system through the release of numerous 
inflammatory markers, including cytokines, acute-phase proteins and 
chemokines8-10. The present study aimed to determine whether the 
presence of leprosy reaction episodes might be associated with dental 
and periodontal infection, and to determine the serum C-reactive 
protein (CRP) and IP-10 levels before and after the elimination of 
oral infections in leprosy patients. 
We selected 38 leprosy patients (29 men and 9 women; mean 
age ± SD: 43.92 ± 2.12 years; range 18-81 years) with and without 
oral infection (OI) before, during or after specific leprosy treatment. 
These patients were divided into two groups: group I consisted 
of leprosy patients presenting some oral infections, and group II 
consisted of leprosy patients without oral infections. The diagnosis 
of leprosy was made based on clinical and histopathological findings, 
and on the Ridley & Jopling classification11, bacilloscopy, biopsy and 
determination of the presence of antibodies to phenolic glycolipid-1 
(anti-PgL-1). The oral infections considered were: periodontal 
diseases (PD), irreversible pulpitis (IP), pulpal necrosis (PN) and 
inflammatory periapical lesions (IPL). Subjects were excluded if 
they presented a coexisting local or systemic infection or diabetes 
mellitus, or if they had received antimicrobial treatment for any 
infections over the previous six months. The trial was approved by 
the local Ethics Committee and all subjects gave written informed 
consent to participate. 
After the patients had been diagnosed with leprosy and oral 
disease, the patients in both study groups (I and II) were instructed 
about oral hygiene techniques and supragingival prophylaxis and the 
patients in group I were treated for their dental and/or periodontal 
diseases. The patients were reexamined seven days after completing 
the treatment for the dental and/or periodontal disease (group I) 
or after the dental prophylaxis (group II). The analysis criteria were 
based on clinical features such as the presence of reactional episodes 
(determined by a blinded examiner), and on laboratory tests such 
as blood counts, urine assay, determination of CRP levels and 
serum quantification of 10kDa interferon-gamma-induced protein 
(IP-10) levels by means of ELISA. Care was taken to maintain 
the same systemic treatment during the analysis in order to avoid 
drug-related variables. The severity of the reactional episodes was 
determined on the basis of the symptoms and the degree of clinical 
skin manifestations and peripheral nerve involvement presented 
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by each patient between the two data collection times. Mean CRP 
and serum IP-10 were calculated for each patient, as well as for each 
group. The results from the two groups were compared using the 
Mann-Whitney test, and baseline values (before) were compared 
with those obtained seven days later, by means of the Wilcoxon rank-
sum test with the aid of the graphPad Prism software (San Diego, 
CA, USA). Significance was set at p < 0.05. 
group I consisted of 19 leprosy patients (13 men and 6 women; 
mean age 45.05 ± 6.3 years; range 18–72 years) presenting some 
oral infections: seven patients presented dental diseases (IP, PN and 
IPL), three presented PD and nine presented a combination of dental 
diseases and PD. In this group, nine patients presented lepromatous 
leprosy (LL), five were borderline lepromatous (BL), three were 
borderline borderline (BB) and two were borderline tuberculoid 
(BT). group II consisted of 19 patients (16 men and 3 women; mean 
age 42.8 ± 13.4 years; range 21–81 years) without oral infections. In 
this group, four patients presented LL, one BL, one BB, nine BT and 
four, the tuberculoid (TT) form. Fifteen (78.9%) of the 19 patients 
in group I presented ENL at the time of diagnosis, three (15.8%) had 
reversal reactions (two BT and one BL patient) and only one (5.3%) 
patient did not present reactional episodes. After the dental and/or 
periodontal disease had been treated, 68.4% (13/19) of group I 
patients presented a clinical improvement in reactional episodes, as 
determined by decreases in skin lesions and symptoms, whereas no 
clinical change was detected in group II. 
C-reactive protein and IP-10 levels did not differ significantly 
between before and after dental treatment in group I, even though 
they tended to become reduced after dental and periodontal 
treatment.  No differences were observed between the two data 
collection times regarding clinical findings or any monitored 
mediators in group II. Serum CRP levels (at baseline) and IP-10 
levels (at baseline and seven days after OI control) were significantly 
higher in group I than in group II (Figures 1 and 2).  
This study attempted to clarify whether chronic OI could 
represent a maintenance factor in leprosy reaction episodes. A 
relationship between focal infection and dermatoses such as 
psoriasis12 and atopic dermatitis13 has been reported, but none 
concerning reactional episodes. It was observed that ENL was more 
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FIGURE 1 - Serum C-reactive protein levels of leprosy patients presenting 
chronic oral infections (Group I) and of leprosy patients without oral infection 
(Group II) before and after chronic oral infection therapy.
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FIGURE 2 - Serum IP-10 levels of leprosy patients presenting chronic oral 
infections (Group I) and of leprosy patients without oral infection (Group II) 
before and after oral infection therapy.
frequent in patients with OI (78.9%) than in patients with absence 
of OI (15.2%). This may have been due to the fact that the elevation 
in inflammatory marker expression by cells in the presence of OI can 
cause a spillover of these markers into the circulation, where they 
can act as a maintenance factor in leprosy reactions, as described 
for other diseases7,8,12,13.
After OI treatment, there was an improvement of clinical 
symptoms in 68.4% (13/19) of the patients in group I. In addition, 
there was an improvement in all of the periodontal clinical parameters 
monitored. However, no improvement was detected in peripheral 
serum levels of CRP or IP-10. The period of seven days after OI 
treatment was probably not sufficient to determine whether there 
were any decreases in serum CRP and IP-10 levels, although there 
was a tendency towards a reduction (Figures 1 and 2). 
We found a significantly higher CRP level in patients with OI 
than in patients without these infections at baseline (p = 0.006). No 
statistically significant difference in serum CRP levels was observed 
between the two groups after OI therapy. We believe that CRP may 
be a diagnostic biomarker of interest, although the significance of 
this finding should be considered with caution since CRP is a general 
inflammatory marker.
Similarly to CRP, we found higher levels of IP-10 in patients with 
OI than in patients without these infections (p = 0.001). This may be 
related to the activity of IP-10, which attracts Th1 cells as a delayed 
hypersensitivity response14. Furthermore, IP-10 expression induced 
by IFNγ has been demonstrated in the skin of a leprosy patient 24 
hours after administration of the classic purified protein derivative 
of tuberculin10. Thus, during the inflammatory reaction of the ENL, 
the increases in serum CRP and IP-10 may be associated with higher 
cell activity and with some bacterial destruction, as determined by 
peripheral inflammatory manifestations. 
Since most of the patients with OI presented reactional episodes 
(78.9%) and showed higher serum CRP and IP-10 levels than those 
without OI, these findings suggest that OI may have stimulated the 
inflammatory reaction. Studies with a larger sample are needed in 
order to support this observation, because dental treatment may 
improve the care for leprosy patients and help prevent disability 
caused by leprosy reactions.
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